Back to mobile site
Get it on Google Play

Biohaven licenses IgG degrader portfolio to Ono for $100M

October 8, 2026 4:00 AM EDT Send to a Friend
Biohaven Ltd. (NYSE: BHVN) has entered into a licensing agreement with Ono Pharmaceutical Co., Ltd. (TYO: 4528), granting Ono an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login